Biochem/physiol Actions

Reversible: yes

Product competes with ATP.

Cell permeable: yes

Target IC₅₀: 3 nM, 27 nM, 170 nM against PDGFRβ, VEGFR2, and FGFR1, respectively

Primary TargetPDGFRB

General description

A cell-permeable pyrrole-indolinone compound that acts as a potent, reversible, and ATP-competitive tyrosine kinase receptor and angiogenic inhibitor that exhibits greater selectivity for PDGFRβ (IC₅₀ = 3 nM), VEGFR2 (IC₅₀ = 27 nM), FGFR1 (IC₅₀ = 170 nM), and Kit family members (IC₅₀ = ~ 10-500 nM) over EGFR (IC₅₀ >20 µM). Reported to display anti-proliferative and pro-apoptotic properties in tumor cells.

A cell-permeable, potent, reversible, and ATP-competitive inhibitor of tyrosine kinase activity of PDGFRβ (IC₅₀ = 3 nM), VEGFR2 (IC₅₀ = 27 nM), FGFR1 (IC₅₀ = 170 nM), and Kit family members (IC₅₀ ~10-500 nM). Does not effect the activity of EGFR (IC₅₀ >20 µM). Reported to display anti-proliferative, antiangiogenic and pro-apoptotic properties in tumor cells.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Heryanto, B., et al. 2003. Reproduction125, 334.Sun, L., et al. 2003. J. Med. Chem.46, 1116.Liao, A.T., et al. 2002. Blood100, 585.

Packaging

Packaged under inert gas

500 µg in Plastic ampoule

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Warning

Toxicity: Standard Handling (A)